Cholesterol boosts the memory of the immune system

December 24, 2012 in Immunology

Cholesterol boosts the memory of the immune system

Enlarge

In a naive cell (left), the receptors (blue) on the membrane are arranged individually. Pathogens (yellow) must bind to many receptors in order to activate the immune defense. In a memory cell (right), the receptors are joined together by cholesterol (red). When a pathogen binds one receptor of a cluster, all of the receptors within the cluster are activated. © Schame

The memory of the human immune system is critical for the development of vaccines. Only if the body recognizes a pathogen with which it has already come into contact in the case of a second infection, the immune system can combat it more effectively than it did the first time. The Freiburg immunobiologist Prof. Dr. Wolfgang Schamel from the Institute of Biology III of the University of Freiburg and his colleagues have succeeded in demonstrating how the memory of the immune system functions. Their findings have now been published in the journals Immunity and Journal of Biological Chemistry (JBC).

The immune system becomes acquainted with a pathogen during an initial infection and understands that it must be combated. When the T cell receptors of the immune system come across the same pathogen a second time, they are much more sensitive toward them than during the first encounter, and it thus takes less to activate the immune system. It was previously unclear why the receptors become more sensitive.

In 2011, Schamel's research group and a team led by Prof. Dr. Balbino Alarcon from the Autonomous University of Madrid, Spain, found the answer to this fundamental question. In a publication in the journal Immunity, they showed that the increased sensitivity is caused by a clustering of the receptors: In a naive cell that has not yet met the pathogen, the receptors are arranged individually on the , each fending for itself. A large number of receptors thus needs to be confronted by a large number of pathogens in order for the immune system to react. In a so-called memory cell, which remembers the pathogen, the receptors are arranged in groups on the membrane. When a pathogen binds to a receptor from a cluster, all of the receptors within the cluster are activated at once. This makes the more sensitive.

Now, as reported in the journal JBC, a team of researchers in Freiburg under Schamel and Prof. Dr. Rolf Schubert, professor for pharmaceutical technology and biopharmaceutics at the Institute of Pharmaceutical Sciences of the University of Freiburg, have succeeded in demonstrating how a cell forms these receptor clusters. The critical factors for the success of this endeavor were Schamel's expertise in biochemical research on T and Schubert's expertise in the production of liposomes. The collaboration between the two teams was made possible by a project funded by BIOSS Centre for Biological Signalling Studies, a Cluster of Excellence at the University of Freiburg.

Dr. Eszter Molnár, a postdoctoral researcher in Schamel's team, and Dr. Martin Holzer from Schubert's research group isolated the receptors and reconstructed them in a synthetic membrane. After one and a half years of work, the scientists achieved a breakthrough: They discovered that the composition of the lipids of a membrane is responsible for the clustering of the receptors. The lipid composition of a naive cell differs from that of a memory cell. Cholesterol is the key factor in this process, as it is present in higher concentrations in a . This higher concentration of cholesterol leads to the aggregation of receptors, because the cholesterol joins them together like glue.

Schamel and Schubert are members of the Freiburg Cluster of Excellence BIOSS Centre for Biological Signalling Studies. Schamel is also a member of the Spemann Graduate School of Biology and Medicine and the Center for Chronic Immunodeficieny of the Freiburg University Medical Center and director of the EU network SYBILLA, which also supported this project.

More information: Increased Sensitivity of Antigen-Experienced T Cells through the Enrichment of Oligomeric T Cell Receptor Complexes, Immunity, Volume 35, Issue 3, 375-387, 08 September 2011, www.cell.com/immun… 761311003566

Cholesterol and Sphingomyelin Drive Ligand-independent T-cell Antigen Receptor Nanoclustering, First Published on October 22, 2012, doi: 10.1074/jbc.M112.386045 December 14, 2012 The Journal of Biological Chemistry, 287, 42664-42674. http://www.jbc.org/cgi/doi/10.1074/jbc.M112.386045

Journal reference: Immunity search and more info website Journal of Biological Chemistry search and more info website

Provided by Albert Ludwigs University of Freiburg search and more info website

5 /5 (3 votes)  

Rank 5 /5 (3 votes)
Related Stories
Relevant PhysicsForums posts

More news stories

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.

Immunology created 13 hours ago | popularity 4.6 / 5 (14) | comments 6 | with audio podcast

Vitamin D could provide new and effective treatments for asthma

(Medical Xpress)—Scientists at King's College London have discovered that Vitamin D has the potential to significantly reduce the symptoms of asthma. The study, led by Professor Catherine Hawrylowicz from ...

Immunology created May 20, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Immune protein could stop diabetes in its tracks

Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been destroyed.

Immunology created May 20, 2013 | popularity 5 / 5 (5) | comments 0 | with audio podcast

Stem-cell-based strategy boosts immune system in mice

Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory. The researchers showed that, in mice, ...

Immunology created May 16, 2013 | popularity 4.8 / 5 (5) | comments 0 | with audio podcast

Resistance to visceral leishmaniasis: New mechanisms involved

Researchers from CNRS, Université Toulouse III - Paul Sabatier and IRD have elucidated new molecular mechanisms involved in resistance to visceral leishmaniasis, a serious parasitic infection. They have shown that dectin-1 ...

Immunology created May 16, 2013 | popularity not rated yet | comments 0


Sugar injections for knee arthritis may ease pain

(HealthDay)—Injections of a sugar solution appear to help relieve knee pain and stiffness related to osteoarthritis, a new study suggests.

Anti-CD47 antibody may offer new route to successful cancer vaccination

(Medical Xpress)—Scientists at the School of Medicine have shown that their previously identified therapeutic approach to fight cancer via immune cells called macrophages also prompts the disease-fighting killer T cells ...

Evaluating a new way to open clogged arteries

Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments ...

Losing weight may ease chronic heartburn

(HealthDay)—Obese and overweight men and women who suffer from heartburn often report relief when they lose weight, a new study shows.

Primary care docs should play role in kids' dental health, experts say

(HealthDay)—When it comes to the care of your children's teeth, dentists aren't the only experts who can help.

ATS: Early prone positioning reduces mortality in ARDS

(HealthDay)—For patients with acute respiratory distress syndrome (ARDS), prolonged prone positioning during mechanical ventilation is associated with significantly reduced mortality at 28 and 90 days, ...